Hedge Fund Rotation: In Q3 2025, hedge funds shifted their investments from consumer discretionary stocks to health care, particularly focusing on biotech companies.
Top Health Care Stocks: Vertex Pharmaceuticals (VRTX) topped the list of health care stocks favored by hedge funds, followed by Bristol Myers Squibb (BMY) and Ocular Therapeutix (OCUL), all receiving bullish ratings from Seeking Alpha's Quant Ratings system.
Quant Ratings Overview: Seeking Alpha's Quant Ratings evaluate stocks based on key metrics, with ratings above 3.5 indicating a bullish outlook, while those at 2.5 or below suggest a bearish perspective.
Health Care ETFs: A variety of health care ETFs were mentioned, reflecting the growing interest in the sector as hedge funds divest from technology stocks.
Wall Street analysts forecast XLV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XLV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast XLV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XLV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 158.260
Low
Averages
High
Current: 158.260
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
